Latest News Releases

News and features

MANCHESTER, UNITED KINGDOM --(Marketwire-October 27, 2008) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, will present results from their latest plucked hair biomarker study at the ASCO-NCI-EORTC Meeting on Molecular Markers in Cancer, Hollywood FL, United States on Friday 31st October 2008. Dr Ged Brady will present data to show that cell cycle genes, previously identified in breast tumour tissue and linked to clinical outcome in breast cancer patients, are also differentially expressed in single intact and dissected plucked hairs from healthy normal volunteers.

27/10/2008

MANCHESTER, UNITED KINGDOM --(Marketwire-September 23 2008) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, will present preclinical results from its recently completed plucked hair biomarker study at the American Association for Cancer Research (AACR) conference, “Molecular Diagnostics in Cancer Therapeutic Development" on 23^rd September 2008. 

22/9/2008

Epistem plc (LSE: EHP), the UK biotechnology company and Rottapharm|Madaus, the multinational pharmaceutical company today announced that favourable results have been obtained with the prophylactic use of CR 3294 in a series of preclinical models for intestinal mucositis.

1/9/2008

Epistem (LSE:EHP), announced today that it has been selected by Humanetics Corporation to provide specialised preclinical efficacy testing services for agents likely to protect the intestinal epithelium from radiation damage. 

24/7/2008

Epistem plc (LSE: EHP), the UK biotechnology company announced today that details of its US National Institute of Health's (NIH) programme for the screening of a number of novel agents for biodefence applications will be presented at the Multinational Association of Supportive Care in Cancer (MASCC) International Symposium of Supportive Care in Houston, Texas, USA from 26^th to 28^th June 2008.

23/6/2008

Epistem plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its cancer stem cell assays will be presented at the international meeting of the American Association for Cancer Research (AACR) at the San Diego Convention Centre, California, USA from 13^th to 16^th April 2008.

7/4/2008

Epistem (LSE:EHP) announced today that Exponential Biotherapies, Inc (EBI). of Virginia, USA, have contracted Epistem to provide their specialised preclinical efficacy testing services for agents likely to protect the gastrointestinal tract against radiation damage. 

3/4/2008

Epistem plc (LSE:EHP) announced today that it had successfully completed a preliminary study with AstraZeneca for the use of its proprietary, minimally invasive plucked human hair biomarker technology to help steer oncology drug development.

28/1/2008